Community Portal

A place for Clinicians and Healthcare Suppliers to share knowledge and learn more about THE CLINICIAN EXCHANGE



Provided by: Medscape

Should the FDA Approve the Mediterranean Diet for Depression?

Published: Thu, 22 Feb 2018 12:37:36 EST
Two studies show impressive improvements in depression scores with a healthy diet high in plant-based foods and omega-3 fats.
Medscape Psychiatry

Lower-Dose Combo Immunotherapy Promising for Advanced Melanoma

Published: Thu, 22 Feb 2018 12:26:38 EST
Dr Jeffrey S. Weber reviews data from an open-label phase 1/2 trial assessing the efficacy and safety of combination pembrolizumab and reduced-dose ipilimumab in patients with advanced melanoma.
Medscape Oncology

'Moving the Needle' in Oncology Workforce Diversity

Published: Thu, 22 Feb 2018 12:04:36 EST
Authors of a recent ASCO statement on diversity discuss their experiences and suggestions for improving inclusivity in the oncology workforce.
Medscape Oncology

Hormone Therapy May Improve Schizophrenia Outcomes

Published: Thu, 22 Feb 2018 11:58:57 EST
A selective estrogen receptor modulator improves outcomes in men and women with schizophrenia when added to treatment with an antipsychotic.
Medscape Medical News
Displaying results 17-20 (of 20)
 1 - 2 - 3 - 4 - 5 


Santhera, reeling from DMD blow, lands cystic fibrosis drug

Published: Thu, 15 Feb 2018 13:12:36 +0000
Santhera Pharmaceuticals has licensed a clinical-phase cystic fibrosis asset from Polyphor. The Swiss biotech penned a CHF 127.5 million ($138 million) deal for the human neutrophil elastase inhibitor to expand its clinical pipeline.

Biogen tweaks Alzheimer’s phase 3, sparking stock slide

Published: Thu, 15 Feb 2018 10:33:02 +0000
Biogen has spooked investors by disclosing midstudy changes to its late-phase Alzheimer’s program. The biotech is adding 510 patients to the phase 3 aducanumab trials after seeing more “variability” than expected in a sample size re-estimation.

Gradually eliminating BACE1 clears amyloid plaque from mice with Alzheimer’s

Published: Wed, 14 Feb 2018 20:25:36 +0000
Cleveland Clinic researchers depleted BACE1 to reverse amyloid plaque formation in mice with Alzheimer's disease, buoying hopes that blocking the enzyme could become a viable treatment for humans.

DIY DNA synthesis for $2 a gene

Published: Wed, 14 Feb 2018 13:55:42 +0000
UCLA scientists were frustrated by the prospect of paying up to $100 per gene from commercial vendors that sell gene sequences for scientific experiments. So they decided to invent a gene-synthesis technology that would allow scientists anywhere to make their own genes quickly and efficiently.
Displaying results 21-24 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy